| CSM004 |
CNS |
| Discovery |
Preclinical |
Phase 1 |
Phase 2 |
Phase 3 |
|
Patent granted - 444456 (10th May 2022) |
| CSMO27 |
Hypertension |
| Discovery |
Preclinical |
Phase 1 |
Phase 2 |
Phase 3 |
|
Provisional filed |
| CSMO21 |
Antiparkinson |
| Discovery |
Preclinical |
Phase 1 |
Phase 2 |
Phase 3 |
|
Provisional filed |
| CSM045 |
Diabetes Mellitus Type 2 |
| Discovery |
Preclinical |
Phase 1 |
Phase 2 |
Phase 3 |
|
Provisional filed |
| CSM046 |
Analgesic Cr Antipyretic |
| Discovery |
Preclinical |
Phase 1 |
Phase 2 |
Phase 3 |
|
Provisional filed |
| CSM047 |
Analgesic |
| Discovery |
Preclinical |
Phase 1 |
Phase 2 |
Phase 3 |
|
Provisional filed |
| CSM048 |
Analgesic |
| Discovery |
Preclinical |
Phase 1 |
Phase 2 |
Phase 3 |
|
Provisional filed |